Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$25.2M Sell
78,296
-3,327
-4% -$1.09M 0.4% 42
2024
Q2
$25.5M Buy
81,623
+11,772
+17% +$3.46M 0.51% 36
2024
Q1
$18.9M Buy
+69,851
New +$20.4M 0.47% 44
2017
Q3
Hold
0
55
2017
Q2
Hold
0
63
2017
Q1
Hold
0
10

Other funds holding AMGN

SpiderRock Advisors's AMGN Position: Q3 2024 in Review

SpiderRock Advisors reduced its Amgen (AMGN) stake by 4.1% in Q3 2024, selling an estimated $1.09M and leaving 78,296 shares worth $25.2M. The position accounts for 0.4% of the portfolio, ranked #42.

SpiderRock Advisors first reported a position in AMGN in Q1 2024 and has held it in 3 quarters since. The position peaked at $25.5M in Q2 2024. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • SpiderRock Advisors held 78,296 shares of Amgen worth $25.2M as of Q3 2024.
  • SpiderRock Advisors sold 3,327 Amgen shares in Q3 2024, an estimated $1.09M.
  • Amgen made up 0.4% of SpiderRock Advisors's portfolio in Q3 2024, its #42 holding.
  • SpiderRock Advisors first reported a position in Amgen in Q1 2024 and has held it in 3 quarters since.
  • SpiderRock Advisors's Amgen position peaked at $25.5M in Q2 2024.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.